Consensus paper on Candida auris by Türkiye EKMUD, ID-IRI, THSK of Ministry of Health of the Republic of Türkiye, KLIMUD, TMC, TARD, and TYBD
EKMUD + MoH THSK + societies · 2025 · Türkiye
Source and licence
- Authors
- Canan AĞALAR, Hakan ERDEM, Yasemin ÇAĞ et al.
- Title
- Consensus paper on Candida auris by Türkiye EKMUD, ID-IRI, THSK of Ministry of Health of the Republic of Türkiye, KLIMUD, TMC, TARD, and TYBD
- Journal
- Turkish Journal of Medical Sciences, 2025
- Licence
- CC BY 4.0
- Changes
- Verbatim excerpts; formatting adapted
Full text retrieved 2026-10-27 from Europe PMC · PMC12419049
Licence statement of the original publication
This work is licensed under a Creative Commons Attribution 4.0 International License.
This page reproduces excerpts of the original publication; the original is authoritative. It has not been reviewed by a physician, does not state a recommendation of Medelix and does not replace medical advice. The guideline may have been updated since.
Open the original publication →Full text on Europe PMC
Recommendations
We found no explicitly labelled recommendations in this publication; its recommendations are in the running text of the original.
Abstract
Candida auris is an emerging fungal pathogen that has become a critical global health concern due to its high antifungal resistance and potential to cause nosocomial outbreaks. Since its initial identification in Japan in 2009, C. auris has spread rapidly, posing significant treatment challenges across various healthcare settings worldwide. The biofilm formation ability of C. auris enhances its resilience against disinfectants and antifungal agents, complicating infection control in healthcare environments. This consensus report was developed by a collaboration between several Turkish medical societies including the Turkish Society of Infectious Diseases and Clinical Microbiology Specialty (EKMUD), the Turkish Society of Anesthesiology and Reanimation (TARD), the Turkish Intensive Care Society (TYBD), the Infectious Diseases – International Research Initiative (ID-IRI), the Clinical Microbiology Specialist Society (KLIMUD), the Turkish Microbiology Society (TMC), and the Public Health Institution of Türkiye (PHIT) under the Ministry of Health. The report provides a comprehensive overview of C. auris and its management, with a focus on the epidemiology, antifungal resistance mechanisms, recommendations for diagnostic and therapeutic challenges, infection control and prevention measures, and surveillance of C. auris. This consensus report aims to establish standardized diagnostic protocols, improve national surveillance systems, and promote effective infection control measures to mitigate C. auris-related health risks in Türkiye. It also offers comprehensive national recommendations and addresses the need for interinstitutional collaboration, improve public health, and strengthen the healthcare response to this pathogen.
Contents of the original publication
The section headings of the original.
- AIMS AND SCOPE
- EPIDEMIOLOGY
- 2.1. Global epidemiology
- 2.2. National epidemiology
- 2.3. Antifungal resistance
- MICROBIOLOGY
- 3.1. Microbiological characteristics of C. auris
- 3.2. Biofilm formation capacity
- 3.3. Antifungal resistance mechanisms
- 3.4. Microbiological diagnosis and diagnostic challenges
- 3.5. Antifungal susceptibility testing
- 3.6. Molecular identification methods
- 3.7. Microbiological screening policy
- 3.9. National diagnostic policy recommendations for C. auris
- C. auris COLONIZATION
- 4.1. Colonization in patients
- 4.2. Surface colonization
- C. auris INFECTIONS
- 5.1. Risk factors facilitating the development of C. auris infections
- 5.2. Infections caused by C. auris
- 5.3. Prognosis of C. auris infections
- TREATMENT
- 6.1. Antifungal treatment
- 6.2. Treatment duration
- 6.3. New antifungals
- 6.4. Antifungal stewardship
- INFECTION CONTROL AND PREVENTION
- 7.1. Hand hygiene
- 7.2. Patient management
- 7.3. Effectiveness of disinfectants on C. auris and disinfectant resistance
- 7.4. Management of waste and soiled linen
- 7.5. Room cleaning upon patient discharge
- SURVEILLANCE RECOMMENDATIONS FOR C. auris
- 8.1. Emergence of the need for surveillance
- 8.2. Emergence of the need for surveillance in Türkiye
- 8.3. Current laboratory infrastructure
- 8.4. Recommendations for developing surveillance infrastructure in Türkiye
- HANDS-ON TRAINING
- 9.1. Planning hands-on training
- 9.2. Selection of educators
- 9.3. Development of training materials
- 9.4. Recommended topics for hands-on training on C. auris
- 9.5. Primary objective of the training
- Preface
A question about this guideline?
Medelix answers clinical questions from guidelines and studies – every statement with its source.
Are you the rights holder and object to this reproduction? Write to contact@medelix.ai and we will take the page down promptly. Imprint